Nyer Medical Group Inc - Notification that Annual Report will be submitted late (NT 10-K)
29 Septiembre 2008 - 4:07PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
Commission
File Number: 000-20175
CUSIP
Number: 670711100
(Check
one): [X] Form 10-K [ ] Form
20-F [ ] Form 11-K [ ] Form
10-Q
[
] Form N-SAR [ ] Form N-CSR
For
Period Ended: June 30, 2008
[
] Transition Report on Form 10-K
[
] Transition Report on Form 20-F
[
] Transition Report on Form 11-K
[
] Transition Report on Form 10-Q
[
] Transition Report on Form N-SAR
For
the Transition Period Ended:
NOTHING
IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS VERIFIED ANY
INFORMATION CONTAINED HEREIN.
If
the notification relates to a portion of the filing checked above, identify the
Item(s) to which the notification relates:
PART
I -- REGISTRANT INFORMATION
Nyer Medical Group,
Inc.
Full
Name of Registrant
N/A
Former
Name if Applicable
1292 Hammond
Street
Address
of Principal Executive Office (Street and Number)
Bangor, Maine
04401
City,
State and Zip Code
PART
II -- RULE 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and
the registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate)
|
[
]
|
(a)
The reason described in reasonable detail in Part III of this form could
not be eliminated without unreasonable effort or
expense.
|
|
[X]
|
(b)
The subject annual report, semi-annual report, transition report on Form
10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof,
will be filed on or before the fifteenth calendar day following the
prescribed due date; or the subject quarterly report or transition report
on Form 10-Q, or portion thereof, will be filed on or before the fifth
calendar day following the prescribed due date;
and
|
|
[
]
|
(c)
The accountant's statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
|
PART
III -- NARRATIVE
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or
the transition report or portion thereof, could not be filed within the
prescribed time period.
The
registrant is not able to file its Form 10-K within the prescribed time period
because it is experiencing delays in the collection of certain information
required to be included in the Form 10-K, most notably in connection with
certain discontinued operations sold on September 25, 2008. The Form
10-K will be filed as soon as reasonably practicable and in no event later than
the fifteenth calendar day following the prescribed due date.
PART
IV -- OTHER INFORMATION
(1)
Name and telephone number of person to contact in regard to this
notification
|
Karen L. Wright
|
(207)
|
942-5273
|
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
(2)
Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer is no,
identify report(s). Yes [X] No [ ]
(3)
Is it anticipated that any significant change in results of operations from the
corresponding period for the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion thereof?
Yes
[X] No [ ]
If
so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
Due
principally to a deemed dividend in redemption of preferred stock of $399,997 in
connection with a series of transactions compromising a change of control of the
registrant in February 2008, the registrant will report a net loss
of
$403,520 for the fiscal year ended June 30, 2008 as compared to a net income of
$86,446 for the fiscal year ended June 30, 2008.
Nyer Medical Group,
Inc.
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
|
Date:
September 29, 2008
|
By:
|
/s/ Karen L.
Wright
|
|
|
Name: Karen
L. Wright
Title: Chief
Financial Officer, Vice President of Finance, Treasurer and
Secretary
|
INSTRUCTION:
The form may be signed by an executive officer of the registrant or by any other
duly authorized representative. The name and title of the person signing the
form shall be typed or printed beneath the signature. If the statement is signed
on behalf of the registrant by an authorized representative (other than an
executive officer), evidence of the representative's authority to sign on behalf
of the registrant shall be filed with the form.
ATTENTION
INTENTIONAL
MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE
18 U.S.C. 1001).
Nyer Medical (NASDAQ:NYER)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Nyer Medical (NASDAQ:NYER)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
